As the internet information retrieval ecosystem continues to evolve, the user decision path in healthcare is undergoing a fundamental change. The old SEO model based on search engine keyword rankings is gradually reaching a growth ceiling. GEO, or Generative Engine Optimization, built on large-model AI Q&A ecosystems, is becoming a new track for OTC pharmaceutical companies to break through user reach. As a service provider deeply focused on life sciences digital intelligence marketing, MeDomino combines years of pharmaceutical industry implementation experience to clarify the underlying logic differences between SEO and GEO. Based on a mature GEO methodology, we implemented a practical project for a cold medicine OTC category, opening a new AI search traffic path for non-prescription drug brands.
1. SEO and GEO: Different Marketing Logic in Two Information Ecosystems
1. Traditional SEO: passive exposure in the keyword search era
Traditional SEO is rooted in traditional search engines. Users actively entering keywords is the traffic entry point. Brand marketing focuses on keyword planning, page ranking optimization, and webpage indexing. Users browse multiple search result pages and independently screen and compare product information. Brands must compete for higher positions among massive search links and passively guide users to browse and reach them.
This model was applicable in the OTC pharmaceutical field for a long time. But as generative AI becomes widely adopted, user habits for obtaining information are changing dramatically, and the original traffic growth logic is increasingly limited.
2. GEO: new rules for active recommendation in the AI-generated Q&A era
GEO means Generative Engine Optimization. It adapts to the new information environment of large-model AI search and Q&A. Today, consumers no longer search individual terms one by one. Instead, they ask AI complete need-based questions, such as "what medicine works quickly for a child's cold and nasal congestion." AI integrates information and generates direct answers with medication recommendations.
The core of GEO is to optimize the exposure probability and recommendation priority of brand information points in AI-generated answers, while correcting misleading information caused by AI hallucinations. It upgrades the goal from "letting users find links" to "letting AI actively mention and prioritize the brand." It is a new-generation content optimization system for AI-native ecosystems.
2. MeDomino's GEO Implementation Thinking: Anchored in Real Medication Q&A Scenarios
MeDomino's GEO service logic is always grounded in real user decision characteristics for pharmaceutical categories. Instead of copying generic optimization templates, it builds an optimization system anchored in the two-way needs of users and AI:
1. Anchor content direction in high-frequency user questions
We go deep into OTC consumer medication scenarios and understand target users such as patients and family members. Based on product characteristics, we focus on high-frequency needs such as fever reduction, nasal congestion, and pediatric medication, which target users care about most. This fits ordinary consumers' short-cycle, light-decision purchasing habits for cold medicine and helps infer the real questions users ask AI in daily life.
2. Refine brand materials according to large-model answer generation rules
We build brand content materials around real user questions and fully adapt them to AI logic. From efficacy, applicable populations, contraindications, and common FAQs, we improve brand-owned content assets so AI has enough credible material when integrating answers and can naturally include brand information.
3. Iterate through long-term data tracking
We use a periodic long-term operating model to monitor brand mention data across AI Q&A scenarios in stages. Based on changes in brand exposure within AI answers, we continuously optimize content and gradually improve the brand's priority in AI recommendation systems.
3. MeDomino Implementation Case: Practical GEO for a Cold Medicine OTC Category
Cold medicine OTC is a highly competitive pharmaceutical market track and a typical light-decision category. Users have short purchase cycles and make decisions quickly, usually asking product questions around fever reduction, nasal congestion, and pediatric medication. This category has become a benchmark scenario for MeDomino's GEO solution.
GEO pain points in this category
1. For high-frequency medication questions from users, AI-generated answers can easily be diluted by generic health education content across the web, making it difficult for brand information to stand out.
2. Because AI tends to prioritize generic drug catalogs, brands often appear lower in AI responses and have a lower probability of first recommendation.
3. The drug's detailed efficacy, suitable populations, contraindications, and other core brand information points are difficult for large models to identify accurately and include in recommendations. Misleading information deviations often appear and may negatively affect patients and family members.
MeDomino's GEO implementation actions
Step 1: User need analysis - restore real cold medicine scenarios
Based on years of MeDomino patient insight experience, we use user probes and demand modeling to accurately identify the core target groups for cold medicine OTC, such as ordinary patients and parents of children, and deeply analyze their core pain points and decision journeys at different stages of a cold.
- Systematically map full-dimensional consultation scenarios for target users around cold medication, focusing on high-frequency question directions such as drug selection, fever reduction, nasal congestion treatment, and pediatric-only medication.
- Simulate different user personas to generate real questions and build a complete question map for the cold medicine category.
- Combine brand business needs to identify high-value conversion questions as the core optimization targets.
Step 2: AI answer monitoring - analyze brand AI visibility across platforms
For mainstream large models such as Doubao, Tongyi Qianwen, Yuanbao, and DeepSeek, we parse and extract insights from AI answers related to cold medication one by one:
- Quantitatively monitor core indicators such as brand mention rate, first mention rate, and sentiment tendency across platforms.
- Analyze how well AI answers match the brand's core selling points, precisely locating missing information and deviations.
- Study large-model source citation preferences and identify high-weight authoritative channels to guide subsequent content placement.
Step 3: Content generation and placement - build compliant and credible brand content assets
- Using the MeDomino Content Hub AIGC content generation system, we generate highly compliant brand content targeted to issues found in AI answers.
- Based on MeDomino's life sciences enterprise knowledge base, and combined with authoritative materials such as the client's package insert and clinical guidelines, we systematically build assets covering product efficacy, detailed usage scenarios, safe medication instructions, and high-frequency FAQ.
- All content undergoes dual medical and compliance review by independent AI agents to ensure it meets relevant regulations.
- The refined compliant content is placed precisely on authoritative media and vertical platforms frequently cited by large models, turning it into trusted sources AI can adopt, helping brand information naturally enter AI recommendation answers and correcting information deviations caused by AI hallucinations.
Step 4: Core data presentation - build a transparent and traceable effectiveness system
Through the GEO monitoring dashboard, we present core brand data in real time and form a continuous closed loop of monitoring, analysis, optimization, and re-monitoring:
- Dynamically track key indicators such as brand mention rate, core focus accuracy, and positive sentiment ratio.
- Regularly generate reports on AI insight competitive landscape, risk points, and optimization strategies.
- Continuously adjust content direction and placement strategy based on data feedback, steadily improving brand priority in AI recommendation systems.
4. Conclusion
The trend of AI reshaping user information acquisition is irreversible. From SEO to GEO, this is not a replacement for past optimization models, but an inevitable upgrade for pharmaceutical brands adapting to the evolution of the information ecosystem. MeDomino continues to stand on pharmaceutical compliance and life sciences professionalism, refining the GEO implementation system for the life sciences industry. Based on real implementation cases, we keep optimizing our services and help more OTC brands find sustainable brand exposure growth paths in the new traffic environment of generative AI.
